vs
Side-by-side financial comparison of Primis Financial Corp. (FRST) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $45.6M, roughly 1.8× Primis Financial Corp.). Primis Financial Corp. runs the higher net margin — 16.0% vs -38.1%, a 54.1% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 13.0%).
Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
FRST vs PRCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $45.6M | $83.1M |
| Net Profit | $7.3M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | — | -4.1% |
| Net Margin | 16.0% | -38.1% |
| Revenue YoY | — | 20.2% |
| Net Profit YoY | 200.0% | -27.9% |
| EPS (diluted) | $0.30 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $45.6M | $83.1M | ||
| Q4 25 | $80.9M | $76.4M | ||
| Q3 25 | $41.0M | $83.3M | ||
| Q2 25 | $43.2M | $79.2M | ||
| Q1 25 | $58.7M | $69.2M | ||
| Q4 24 | $38.8M | $68.2M | ||
| Q3 24 | $37.3M | $58.4M | ||
| Q2 24 | $35.7M | $53.4M |
| Q1 26 | $7.3M | $-31.6M | ||
| Q4 25 | $29.5M | $-29.8M | ||
| Q3 25 | $6.8M | $-21.4M | ||
| Q2 25 | $2.4M | $-19.6M | ||
| Q1 25 | $22.6M | $-24.7M | ||
| Q4 24 | $-26.2M | $-18.9M | ||
| Q3 24 | $1.2M | $-21.0M | ||
| Q2 24 | $3.4M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 44.8% | -40.6% | ||
| Q3 25 | 21.3% | -27.8% | ||
| Q2 25 | 6.9% | -28.0% | ||
| Q1 25 | 41.9% | -39.7% | ||
| Q4 24 | -123.0% | -28.9% | ||
| Q3 24 | -3.1% | -38.4% | ||
| Q2 24 | 7.8% | -50.3% |
| Q1 26 | 16.0% | -38.1% | ||
| Q4 25 | 36.5% | -39.1% | ||
| Q3 25 | 16.7% | -25.7% | ||
| Q2 25 | 5.6% | -24.7% | ||
| Q1 25 | 38.6% | -35.8% | ||
| Q4 24 | -100.3% | -27.6% | ||
| Q3 24 | 3.3% | -35.9% | ||
| Q2 24 | 9.6% | -48.0% |
| Q1 26 | $0.30 | $-0.56 | ||
| Q4 25 | $1.19 | $-0.54 | ||
| Q3 25 | $0.28 | $-0.38 | ||
| Q2 25 | $0.10 | $-0.35 | ||
| Q1 25 | $0.92 | $-0.45 | ||
| Q4 24 | $-0.95 | $-0.34 | ||
| Q3 24 | $0.05 | $-0.40 | ||
| Q2 24 | $0.14 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.9M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $427.2M | $347.7M |
| Total Assets | $4.3B | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $159.9M | $245.6M | ||
| Q4 25 | $143.6M | $286.5M | ||
| Q3 25 | $63.9M | $294.3M | ||
| Q2 25 | $94.1M | $302.7M | ||
| Q1 25 | $57.0M | $316.2M | ||
| Q4 24 | $64.5M | $333.7M | ||
| Q3 24 | $77.3M | $196.8M | ||
| Q2 24 | $66.6M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | $427.2M | $347.7M | ||
| Q4 25 | $422.9M | $365.9M | ||
| Q3 25 | $382.2M | $380.3M | ||
| Q2 25 | $376.4M | $385.8M | ||
| Q1 25 | $375.6M | $389.2M | ||
| Q4 24 | $351.8M | $402.2M | ||
| Q3 24 | $381.0M | $241.2M | ||
| Q2 24 | $376.0M | $251.8M |
| Q1 26 | $4.3B | $487.1M | ||
| Q4 25 | $4.0B | $508.1M | ||
| Q3 25 | $4.0B | $511.5M | ||
| Q2 25 | $3.9B | $513.1M | ||
| Q1 25 | $3.7B | $519.4M | ||
| Q4 24 | $3.7B | $534.0M | ||
| Q3 24 | $4.0B | $374.1M | ||
| Q2 24 | $4.0B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FRST
| Net Interest Income | $32.1M | 70% |
| Noninterest Income | $13.6M | 30% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
